In a recent statement, Zhao Yan, chairperson and CEO of China\u2019s Bloomage Biotechnology, emphasized that "technological strength is the key advantage that enables Chinese companies to compete with international brands in the global market."
Founded in 2002, Bloomage has evolved from a domestic producer of hyaluronic acid into a global biotech leader, supplying ingredients for top skincare lines across Europe, North America and Asia. The company\u2019s journey underscores how robust R&D capabilities and a growing patent portfolio can unlock new opportunities far beyond the Chinese mainland.
Chinese enterprises are boosting their research investment, with R&D spending climbing to over 2.5 percent of GDP in 2022. Last year, patent applications from China accounted for nearly 45 percent of global filings, signaling a shift from manufacturing-driven growth to innovation-led expansion.
By harnessing advanced technologiesāsuch as AI-powered drug discovery platforms and sustainable fermentation processesāChinese brands are developing standout products that resonate with consumers worldwide. Bloomage\u2019s recent collaboration with a leading European cosmetics group highlights the global appetite for homegrown biotech solutions in premium markets.
Beyond the lab, savvy digital strategies are amplifying reach. From livestream shopping on cross-border e-commerce platforms to virtual product launches, tech-driven marketing is boosting brand visibility across G20 nations and emerging economies alike.
As Zhao Yan puts it, "When Chinese brands take innovation to the next level, they don\u2019t just join the global stage\u2014they help define it." For entrepreneurs and investors, the takeaway is clear: tech power is now the passport to worldwide success.
Reference(s):
Bloomage CEO: Tech power key to building global Chinese brands
cgtn.com
